LSD Marijuana Strain Overview

LSD is a potent hybrid strain that’s as rare as it is delicious.

lsd
(Photo: MedicalMarijuanaStrains.com)

LSD isn’t a common strain in cannabis retail outlets or dispensaries; this is also true of the black-market. When people do come across it, they tend to be blown away by its taste, smell and pleasant high.

LSD owes it lineage to the Mazar-I-Sharif and Skunk #1 marijuana strains. It has a sweet, almost citrusy taste and smell that rarely disappoints. With an average THC percentage of around 24%, it’s a potent strain that delivers a pleasant and powerful body high.

The top effects of the LSD marijuana strain are:

  • Relaxation
  • Happiness
  • Burst of creativity
  • A strong body high and also
  • A pleasant and relatively subtle head high

Medical properties:

Some of the top medical ailments it helps with are:

  • Pain
  • Stress
  • Depression
  • Anxiety and also
  • Headaches and Migraines

Growing information:

According to Leafly, it is a disease-resistant strain that does well in most growing conditions. On average it yields 600 grams per square meter; the flowering time is approximately 8 to 9 weeks.

Reviews:

At the time of publication LSD has 611 reviews on Leafly with an average score of 4.4 out of 5 (8.8 out of 10).

Where to find it

If you are lucky enough to live in a state where cannabis is legal for medical and/or recreational purposes, we suggest you check out Leafly’s strain finder.

This feature can use your exact location to find the closet cannabis store or dispensary to you that is currently carrying the LSD marijuana strain; you can also look for a variety of other strains.

Click here for the strain finder.

Study: Psychedelic Drugs May Treat Anxiety, Addiction and Post Traumatic Stress Disorder

A psilocybin, or "magic", mushroom.
A psilocybin, or “magic”, mushroom.

By Alan Mozes, HealthDay Reporter

In a carefully controlled setting, psychedelic drugs such as LSD or “magic mushrooms” may benefit patients with hard-to-treat anxiety, addiction or post-traumatic stress disorder (PTSD), new research suggests.

The finding comes from a review of small-scale and preliminary studies conducted recently in the United States, Canada and Europe, all of which await follow-up.

These preliminary results show that “in the right context, these drugs can help people a lot, especially people who have disorders that we generally treat poorly, such as end-of-life distress, PTSD, and addiction issues involving tobacco or alcohol,” said study co-author Matthew Johnson. Johnson is an associate professor in the department of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine in Baltimore.

Read moreStudy: Psychedelic Drugs May Treat Anxiety, Addiction and Post Traumatic Stress Disorder

Study: Prohibition on Psychedelics a Violation of Human Rights, Their Use not a Risk Factor for Mental Health Problems

A psilocybin mushroom, which produces a hallucinogenic response when consumed.
A psilocybin mushroom, which produces a hallucinogenic response when consumed.

A study of over 130,000 adults, published this month by the Journal of Psychopharmacology, has found that the use of psychedelics such as LSD and magic mushrooms is not a risk factor for mental health problems. Researchers conclude that the prohibition on such drugs is difficult to justify, and is a violation against human rights.

Using a data set consisting of 135,095 randomly selected United States adults, including 19,299 psychedelic users, researchers examined “the associations between psychedelic use and mental health.”

Read moreStudy: Prohibition on Psychedelics a Violation of Human Rights, Their Use not a Risk Factor for Mental Health Problems

New Study: LSD Reduces Anxiety In Those With Terminal Illnesses

New data published online by the Journal of Nervous and Mental Disease has found that LSDlsd therapy can significantly reduce anxiety in those who have life-threatening diseases. This is the first controlled trial data on LSD to be released in more than 40 years.

“A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases”, claims the study’s author Dr. Peter Gasser.

Read moreNew Study: LSD Reduces Anxiety In Those With Terminal Illnesses

New Study Finds Psychedelic Drugs Reduce Risk Of Mental Illness

Amid a slew of propaganda that would lead the populace to believe otherwise,inspiration information is coming to light offering evidence that psychedelic drug use has benefits.

Recently, researchers at the Norwegian University of Science and Technology’s Department of Neuroscience examined data collected from more than 130,000 Americans in the National Survey on Drug Use and Health, in an effort to determine what kind of effect psychedelics have on mental health.

Read moreNew Study Finds Psychedelic Drugs Reduce Risk Of Mental Illness